Medical device manufacturer Biomet Inc will pay at least $56 million to settle a multidistrict lawsuit relating to defective hip replacements. The litigation involves the Biomet M2a Magnum and M2a 28 metal-on-metal hip replacement devices. The combined Biomet lawsuits were jointly heard at the federal court of Indiana, where Biomet is headquartered.
The multidistrict ligation began in October 2012 and includes over 700 Biomet lawsuits. Lawsuits consolidated in this multidistrict litigation claim that the Biomet M2a 38 and M2a Magnum hip replacement systems fail early and generate high levels of metal ions in the bloodstream. The high levels of metal ions occur as a result of the implant’s metal-on-metal design and can lead to metallosis, or metal poisoning.
According to a Reuters, plaintiffs who received the Biomet M2a Magnum or M2a 38 hip replacement system as part of an initial hip replacement that was rectified more than 180 days after it was implanted are eligible for a base award of $200,000.